We have located links that may give you full text access.
The biopsychosocial-spiritual factors influencing relapse of patients with schizophrenia.
International Journal of Social Psychiatry 2021 December 29
OBJECTIVE: High relapse rate of patients with schizophrenia has a large impact on patients and their families that can be reviewed from biopsychosocial and spiritual factors. Determining all the potential risk factors of relapse in schizophrenia can help increase awareness of physicians, patients, and families. Physicians are the ones who examine patients and have responsibility to manage and educate them and expect to prevent relaps. This study analyze various biopsychosocial and spiritual factors affecting relapse occurrence in patients with schizophrenia.
METHODS: Cross sectional observational analytic study on 226 subjects with schizophrenia in three places in East Java, Indonesia, namely Soetomo Academic Hospital Surabaya (33.2%), Menur Hospital Surabaya (32.7%), and Radjiman Wediodiningrat Mental Hospital Lawang (34.1%) that met the inclusion and exclusion criteria. Data collection including 33 biopsychosocial and spiritual factors and were analyzed using bivariate and multivariate logistic regression.
RESULTS: Relapse rate within 1 year was 59.73%. There were 12 factors significantly affected the relapse of schizophrenia, namely history of physical disease of mothers during pregnancy ( p < .001; B = 27.31; 95% CI 3.96-188.52), presence of trigger ( p < .000; B = 6.25; 95% CI 2.61-14.96), negative beliefs ( p < .000; B = 4.94; 95% CI 2.10-11.61), hereditary factors ( p < .001; B = 4.84; 95% CI 1.93-12.10), insight ( p < .003; B = 4.27; 95% CI 1.62-11.27), 1-year GAF Scale ( p < .015; B = 3.79; 95% CI 1.30-11.09), response to treatment ( p < .006; B = 3.68; 95% CI 1.45-9.36), family knowledge ( p < .011; B = 3.23; 95% CI 1.31-7.93), history of head trauma ( p < .029; B = 3.13; 95% CI 1.13-8.69), medication side effects ( p < .028; B = 2.92; 95% CI 1.12-7.61), substance use history ( p < .031; B = 2.86; 95% CI 1.10-7.45), and occupation ( p < .040; B = 2.40; 95% CI 1.04-5.52).
CONCLUSIONS: The 12 factors of biopsychosocial-spiritual are determinant to predict the risk of relapse in patients with schizophrenia. These factors should be emphasized in psychoeducation for patients and their families to enable intervention and relapse prevention.
METHODS: Cross sectional observational analytic study on 226 subjects with schizophrenia in three places in East Java, Indonesia, namely Soetomo Academic Hospital Surabaya (33.2%), Menur Hospital Surabaya (32.7%), and Radjiman Wediodiningrat Mental Hospital Lawang (34.1%) that met the inclusion and exclusion criteria. Data collection including 33 biopsychosocial and spiritual factors and were analyzed using bivariate and multivariate logistic regression.
RESULTS: Relapse rate within 1 year was 59.73%. There were 12 factors significantly affected the relapse of schizophrenia, namely history of physical disease of mothers during pregnancy ( p < .001; B = 27.31; 95% CI 3.96-188.52), presence of trigger ( p < .000; B = 6.25; 95% CI 2.61-14.96), negative beliefs ( p < .000; B = 4.94; 95% CI 2.10-11.61), hereditary factors ( p < .001; B = 4.84; 95% CI 1.93-12.10), insight ( p < .003; B = 4.27; 95% CI 1.62-11.27), 1-year GAF Scale ( p < .015; B = 3.79; 95% CI 1.30-11.09), response to treatment ( p < .006; B = 3.68; 95% CI 1.45-9.36), family knowledge ( p < .011; B = 3.23; 95% CI 1.31-7.93), history of head trauma ( p < .029; B = 3.13; 95% CI 1.13-8.69), medication side effects ( p < .028; B = 2.92; 95% CI 1.12-7.61), substance use history ( p < .031; B = 2.86; 95% CI 1.10-7.45), and occupation ( p < .040; B = 2.40; 95% CI 1.04-5.52).
CONCLUSIONS: The 12 factors of biopsychosocial-spiritual are determinant to predict the risk of relapse in patients with schizophrenia. These factors should be emphasized in psychoeducation for patients and their families to enable intervention and relapse prevention.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app